project id: TCGA-ESCA; case submitter id: TCGA-IG-A51D; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.66; rna integrity number: 9.1; age at index: 63; days to birth: -23259; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23259; ajcc clinical m: M1; ajcc clinical n: NX; ajcc clinical stage: Stage IV; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 518.0; icd 10 code: C15.3; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper third of esophagus; synchronous malignancy: No; tissue or organ of origin: Upper third of esophagus; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 135; days to sample procurement: 0; initial weight: 570.0; portion submitter id: TCGA-IG-A51D-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0;